Pressmeddelanden

Coegin Pharma establishes own agile production facility in Denmark - ensuring control, scalability, and cost efficiency for next phase of growth Coegin Pharma AB ("Coegin" or "the Company") provides a status update about the establishment of its own agile production facility in Denmark. It enables the Company to secure fu...
REG MAR
Coegin Pharma enters collaboration with Polish distributor Mercapharm - expands Follicopeptide® commercialisation to Poland Coegin Pharma AB ("Coegin" or "the Company") has entered a distribution agreement with Mercapharm, a fast-growing Polish distributor, through the signing of a limited purchase or...
REG MAR
Coegin Pharma enters collaboration with Swedish retailer Gents - kicks off next phase of Follicopeptide commercialisation Coegin Pharma AB ("Coegin" or "the Company") has entered a distribution agreement with the Swedish premium retail company Gents AB through the signing of a first limited purchase...
REG
Coegin Pharma AB (publ) publishes its Interim Report for the second quarter of 2025 Summary of the Interim ReportThe second quarter of 2025 has been defined by intense preparation for one of the most important milestones in Coegin Pharma's history - the upcoming...
Coegin Pharma provides status update ahead of the upcoming commercialisation of its first Follicopeptide-based hair growth product The company is pleased to inform that the commercialisation of the first Follicopeptide-based product, expected by the end of this year, is firmly on schedule. Commercial scale p...
REG
Coegin Pharma ändrar språk för informationsgivning till engelska Coegin Pharma meddelar härmed att bolaget ändrar språk för informationsgivning till endast engelska. Detta innebär att finansiella rapporter och pressmeddelanden endast kommer at...
Visa fler pressmeddelanden

Rapporter

Datum Rubrik
Quarterly report Q2
Delårsrapport Q1 2025
Quarterly report Q1 2025

Video

Finansiell kalender

Delårsrapport Q3 2025 Delårsrapport
Bokslutskommuniké 2025 Bokslutskommuniké

Om Coegin Pharma

Coegin Pharma är ett svenskt bioteknikföretag som utvecklar banbrytande innovationer för hår och hud.

Webbplats
www.coeginpharma.com
Bransch
Bioteknik

Prenumerera

Få löpande information från Coegin Pharma via e-post.

Språk
Nyhetstyper

Handelsinformation

Kurs 6,88 SEK (2025-10-10)
Förändring 67,8% (2024-10-14)
Marknad NGM Nordic SME Kortnamn COEGIN ISIN-kod SE0020357754

IR-Kontakt

Jens Eriksson vd [email protected]